Clinical association with urinary glycosaminoglycans and urolithiasis

Urology

Volumn 59, Issue 4, 2002, Pages 495-499

  Erturk, Erdal ^a   Kiernan, Maureen ^a   Schoen, Susan R ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DYE; GLYCOSAMINOGLYCAN;

ADULT; AGED; ARTICLE; ASSAY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HUMAN; MALE; NEPHROLITHIASIS; PRIORITY JOURNAL; RECURRENT DISEASE; SEX DIFFERENCE; STONE FORMATION; URETER STONE; URINALYSIS; URINE LEVEL; UROLITHIASIS;

ADULT; AGED; AZURE STAINS; CASE-CONTROL STUDIES; CREATININE; FEMALE; GLYCOSAMINOGLYCANS; HUMANS; KIDNEY CALCULI; MALE; MIDDLE AGED; SEX FACTORS; URETERAL CALCULI;

EID: 0036127331     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01649-1     Document Type: Article

References (32)

1. Saturation inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract
2. Inhibitors of stone formation
3. Significance of glycosaminoglycans for the formation of calcium oxalate stones
4. Surface interaction between glycosaminoglycans and calcium oxalate
5. A study of inhibitory effect of chondroitin polysulfate on stone formation of calcium oxalate
6. Inhibitory factor of calcium oxalate crystal growth in urinary macromolecules
7. Urinary excretion of citrate, glycosaminoglycans, magnesium and zinc in relation to age and sex in normal subjects and in patients who form calcium stones
8. Role of inhibitor deficiency in urolithiasis; rationale of urinary magnesium, citrate, pyrophosphate and glycosaminoglycans determinations
9. Glycosaminoglycans in urolithiasis
10. Glycosaminoglycans and oxalocalcic urolithiasis
11. Comparative study of 24-hour urinary excretion of glycosaminoglycans by renal stone formers and healthy adults
12. A new quantitative assay for glycosaminoglycans
13. A modified screening test for glycosaminoglycan excretion
14. The quantitative spectrophotometric estimation of total sulfated glycosaminoglycan levels; Formation of soluble Alcian blue complexes
15. Results of a quality assurance exercise for urinary glycosaminoglycan excretion
16. Urinary excretion of glycosaminoglycans in normal and stone forming subjects
17. Urinary glycosaminoglycan excretion in normal and stone-forming subjects; significant disturbance in recurrent stone formers
18. Study of inhibition mechanisms of glycosaminoglycans on calcium oxalate monohydrate crystals by atomic force microscopy
19. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls
20. Inhibitors of stone formation
21. Glycosaminoglycans and semisynthetic sulfated polysaccharides; an overview of their potential application in the treatment of patients with urolithiasis
22. Glycosaminoglycans as inhibitors of stone formation
23. Quantitative analysis on the localization of chondroitin sulfate proteoglycan in renal tissues of patients with calcium nephrolithiasis
24. Urinary risk factors in calcium oxalate stone disease; comparison of men and women
25. Urinary glycosaminoglycan excretion in urolithiasis
26. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine
27. Extracorporeal shock wave lithotripsy and glycosaminoglycans in urine
28. Does urinary oxalate interfere with the inhibitory role of glycosaminoglycans and semisynthetic sulfated polysaccharides in calcium oxalate crystallization?
29. Uric acid and its relationship with glycosaminoglycans in normal and stone-former subjects
30. Glycose aminoglycane excretion and concentration in the urine of patients with frequently recurrent calcium-oxalate lithiasis prior to and following Diclofenac-Na therapy
31. Treatment of renal calcium stone disease with the synthetic glycosaminoglycan pentosan polysulphate
32. Influence of sodium pentosan polysulphate and certain inhibitors on calcium oxalate crystal growth